Drug Profile
Research programme: drug discovery - Thrombotargets/Instituto Biomar
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Thrombotargets Corporation
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Blood coagulation disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Coagulation-disorders in USA
- 28 Apr 2009 Early research in Coagulation disorders in USA (unspecified route)